
Arun J. Sanyal
@arunjsanyalvcu
The views expressed here do not necessarily reflect those of VCU or its medical school or the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health.
ID: 1689283345539031041
https://liverinstitute.medschool.vcu.edu 09-08-2023 14:32:12
348 Tweet
710 Takipçi
92 Takip Edilen

On Feb. 12, we welcome #VCU colleague Michael Miles, MD, PhD, to the institute's research webinar. Join us at bit.ly/4hgEd1U #livertwitter #alcohol #alcoholism


🤩 AASLD President-elect, Saul Karpen highlighting the growth of VCU Stravitz-Sanyal Institute for Liver Disease - a metabolic institute with multidisciplinary management VCU Health ⭐️ Liver-centric, not liver-exclusive approach 🔥 Catalysing a liver revolution with pre-clinical imaging 🩻, data science 💾,


With our Saul Karpen, whose efforts in this area led in 2019 to the identification of the first genetic defect linked to BA #livertwitter Juan Pablo (JP) Arab, MD Jasmohan Bajaj

🔗: bit.ly/3XMKCe1 Pediatricians are getting a simple three-step approach for identifying biliary atresia, based on research by Saul Karpen of VCU Stravitz-Sanyal Institute for Liver Disease.


Our director of alcohol sciences, Juan Pablo (JP) Arab, MD




See what my colleague Juan Pablo (JP) Arab, MD has to say on his review: vcuhealth.org/news/what-you-…


Inspiring day at the 29th Annual Virginia GI Symposium and Liver Update by VCU Health! 🎤📚 Truly honored to celebrate Dr. Alvin Zfass — a pioneer in #Endoscopy and #GI, mentor to 200+ fellows, and a lifelong champion for trainees. 🏆🙏 A legacy that continues to inspire us all!


Want to know where our faculty's research will be featured at #DDW2025? Check out our dedicated Digestive Disease Week page for a day-by-day schedule of presentations, talks and posters affiliated with the institute and #VCU. #livertwitter bit.ly/42S9xPj




Appreciate my colleague Jasmohan Bajaj's expertise on this topic as we seek to improve treatment for liver patients with HR.

In Hepatology Communications journals.lww.com/hepcomm/fullte…

Thrilled to announce the release of the new American Diabetes Association - DiabetesPro Consensus Statement: #MASLD is now recognized as a major metabolic complication in type 2 diabetes and obesity, underscoring the central role of insulin resistance and cardiometabolic risk factors in its pathogenesis.


A great day for liver researchers at VCU. We want to make lives better, not just here, but around the world. Thanks to those who made this day happen -- Saul Karpen and others -- and to the participants for really being keyed into the presentations and activities.